These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Acadesine induces apoptosis in B cells from mantle cell lymphoma and splenic marginal zone lymphoma. Campàs C; Santidrián AF; Domingo A; Gil J Leukemia; 2005 Feb; 19(2):292-4. PubMed ID: 15549145 [No Abstract] [Full Text] [Related]
26. Rituximab as therapy for acute lymphoblastic leukemia. Thomas DA Clin Adv Hematol Oncol; 2010 Mar; 8(3):168-71. PubMed ID: 20400931 [No Abstract] [Full Text] [Related]
27. Acadesine (AICA riboside) attenuates reperfusion injury and oxidant-induced damage of the heart. Metzner EK; Fox MH; Potter S; Mullane KM; Bullough DA Adv Exp Med Biol; 1991; 309A():347. PubMed ID: 1789240 [No Abstract] [Full Text] [Related]
28. The unorthodox and orthodox: the therapeutic role of acadesine after traumatic injury and sepsis. Unkle DW Crit Care Med; 1999 Mar; 27(3):468-9. PubMed ID: 10199518 [No Abstract] [Full Text] [Related]
30. Synthesis of carbocyclic purine nucleosides using key intermediates, carbocyclic AICA-ribosides. Marumoto R; Taniyama Y; Fukuda T Nucleic Acids Symp Ser; 1987; (18):37-40. PubMed ID: 3697147 [TBL] [Abstract][Full Text] [Related]
31. Regulation of adenosine concentrations by acadesine (AICA-riboside) in human B-lymphoblasts. Barankiewicz J; Jimenez R; Uyesaka J; Gruber HE Adv Exp Med Biol; 1991; 309A():275-8. PubMed ID: 1789225 [No Abstract] [Full Text] [Related]
32. A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia. Litzow MR; Lee S; Bennett JM; Dewald GW; Gallagher RE; Jain V; Paietta EM; Racevskis J; Rousey SR; Mazza JJ; Tallman MS Haematologica; 2006 Aug; 91(8):1105-8. PubMed ID: 16870552 [TBL] [Abstract][Full Text] [Related]
33. [High-risk acute lymphoblastic leukemia. Results of a diagnostic-therapeutic protocol]. Castell V; Verdaguer A; Ferris J; Piqueras AI; Fernández JM An Esp Pediatr; 1988 Oct; 29 Suppl 34():89-91. PubMed ID: 3214045 [No Abstract] [Full Text] [Related]
34. [High-risk acute lymphoblastic leukemia]. Martínez Rubio A; Doñoro Mazario M; Sánchez Luna M; Muro Brussi M; Lamamie de Cleirac P; García-Monge Santidrián S An Esp Pediatr; 1988 Oct; 29 Suppl 34():66-8. PubMed ID: 3214041 [No Abstract] [Full Text] [Related]
35. Acute lymphoblastic leukemia in adolescents and young adults in Finland. Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413 [TBL] [Abstract][Full Text] [Related]
36. Curability of cancer in childhood and adolescence: acute lymphoblastic leukemia. Mann G; Gadner H Wien Klin Wochenschr; 2002 Feb; 114(4):141-2. PubMed ID: 12060979 [No Abstract] [Full Text] [Related]
37. Pancreatic pseudocyst complicating treatment of acute lymphoblastic leukemia. Tomar S; Bakhshi S; Kabra SK; Arya LS Indian Pediatr; 2003 Jul; 40(7):670-2. PubMed ID: 12881625 [No Abstract] [Full Text] [Related]
38. AICA-riboside: direct quantitation in ultrafiltrates of plasma by HPLC during pharmacokinetic studies in man. Dixon R; Fujitaki J; Chrastil L; Lee J Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):405-8. PubMed ID: 2813961 [TBL] [Abstract][Full Text] [Related]
39. Biology and treatment of acute lymphoblastic leukemia. Pieters R; Carroll WL Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313 [TBL] [Abstract][Full Text] [Related]
40. Adherence to oral chemotherapy in childhood acute lymphoblastic leukemia: an evolutionary concept analysis. Landier W Oncol Nurs Forum; 2011 May; 38(3):343-52. PubMed ID: 21531684 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]